We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNTM
12601
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$120K ﹤0.01%
1,057
-85
-7% -$9.86K
RAAS
12602
PUT
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$120K ﹤0.01%
4,733
+33
+0.7% +$981
ADFI
12603
DELISTED
Anfield Dynamic Fixed Income ETF
ADFI
$119K ﹤0.01%
+12,249
New +$119K
CTMX icon
12604
PUT
CytomX Therapeutics
CTMX
$732M
$119K ﹤0.01%
18,800
-5,800
-24% -$45.2K
DBVT
12605
DBV Technologies
DBVT
$881M
$119K ﹤0.01%
2,183
+243
+13% +$14.5K
GDL
12606
GDL Fund
GDL
$91.7M
$119K ﹤0.01%
13,101
+94
+0.7% +$843
IZEA icon
12607
CALL
IZEA Worldwide
IZEA
$53.5M
$119K ﹤0.01%
11,700
-16,525
-59% -$217K
SST icon
12608
PUT
System1
SST
$24.6M
$119K ﹤0.01%
+1,200
New +$119K
STGW icon
12609
PUT
Stagwell
STGW
$2.23B
$119K ﹤0.01%
20,400
-6,200
-23% -$29K
SVRA icon
12610
CALL
Savara
SVRA
$1.11B
$119K ﹤0.01%
69,900
+13,900
+25% +$25K
CNSL
12611
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$119K ﹤0.01%
13,500
-8,600
-39% -$69.1K
ACGN
12612
CALL
DELISTED
Aceragen Inc
ACGN
$119K ﹤0.01%
5,841
-571
-9% -$11.5K
EXTN
12613
DELISTED
Exterran Corporation
EXTN
$119K ﹤0.01%
+25,084
New +$107K
YSAC.U
12614
DELISTED
Yellowstone Acquisition Company Units, each consisting of one share of Class A common stock and one-
YSAC.U
$119K ﹤0.01%
11,442
+356
+3% +$3.69K
AGS
12615
CALL
DELISTED
PlayAGS
AGS
$118K ﹤0.01%
11,900
-1,700
-13% -$15.7K
FOCL
12616
EDAP TMS S.A.
FOCL
$178M
$118K ﹤0.01%
+16,691
New +$121K
LINC icon
12617
Lincoln Educational Services
LINC
$950M
$118K ﹤0.01%
15,107
-7,161
-32% -$51.2K
MRCC
12618
CALL
DELISTED
Monroe Capital Corp
MRCC
$118K ﹤0.01%
11,000
-3,500
-24% -$37.9K
OVID icon
12619
PUT
Ovid Therapeutics
OVID
$553M
$118K ﹤0.01%
30,300
-95,300
-76% -$376K
TXMD icon
12620
PUT
TherapeuticsMD
TXMD
$24M
$118K ﹤0.01%
1,982
-1,716
-46% -$104K
EGLX
12621
PUT
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$118K ﹤0.01%
+19,900
New +$135K
NMTR
12622
CALL
DELISTED
9 Meters Biopharma
NMTR
$118K ﹤0.01%
5,380
-455
-8% -$11.2K
CND.U
12623
DELISTED
Concord Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
CND.U
$118K ﹤0.01%
11,434
-6,232
-35% -$63.8K
AFI
12624
CALL
DELISTED
Armstrong Flooring, Inc.
AFI
$118K ﹤0.01%
19,000
-8,700
-31% -$49.9K
PAE
12625
PUT
DELISTED
PAE Incorporated Class A Common Stock
PAE
$118K ﹤0.01%
13,300
-2,600
-16% -$22.4K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.